Bridgewater Associates’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $61M | Sell |
228,493
-115,959
| -34% | -$32.1M | 0.27% | 65 |
|
|
2025
Q4 | $94.8M | Sell |
344,452
-258,687
| -43% | -$72.5M | 0.35% | 46 |
|
|
2025
Q3 | $174M | Sell |
603,139
-13,487
| -2% | -$3.99M | 0.68% | 28 |
|
|
2025
Q2 | $204M | Buy |
616,626
+75,444
| +14% | +$24.3M | 0.82% | 27 |
|
|
2025
Q1 | $178M | Sell |
541,182
-38,300
| -7% | -$11.5M | 0.83% | 29 |
|
|
2024
Q4 | $160M | Buy |
579,482
+255,646
| +79% | +$81.5M | 0.73% | 18 |
|
|
2024
Q3 | $112M | Buy |
323,836
+41,140
| +15% | +$14.2M | 0.64% | 33 |
|
|
2024
Q2 | $93.5M | Sell |
282,696
-66,949
| -19% | -$23.1M | 0.49% | 41 |
|
|
2024
Q1 | $127M | Sell |
349,645
-24,045
| -6% | -$7.92M | 0.64% | 33 |
|
|
2023
Q4 | $112M | Buy |
373,690
+152,413
| +69% | +$44.5M | 0.63% | 33 |
|
|
2023
Q3 | $63.3M | Buy |
221,277
+59,663
| +37% | +$17M | 0.38% | 52 |
|
|
2023
Q2 | $45.3M | Sell |
161,614
-42,803
| -21% | -$11.1M | 0.28% | 75 |
|
|
2023
Q1 | $52.2M | Buy |
204,417
+24,514
| +14% | +$7.14M | 0.32% | 64 |
|
|
2022
Q4 | $59.6M | Buy |
179,903
+11,681
| +7% | +$3.7M | 0.33% | 66 |
|
|
2022
Q3 | $46.7M | Sell |
168,222
-61,389
| -27% | -$17.3M | 0.24% | 86 |
|
|
2022
Q2 | $60.5M | Buy |
229,611
+128,430
| +127% | +$33.1M | 0.26% | 81 |
|
|
2022
Q1 | $24.2M | Buy |
101,181
+74,247
| +276% | +$17.4M | 0.1% | 152 |
|
|
2021
Q4 | $6.18M | Buy |
26,934
+18,572
| +222% | +$3.95M | 0.04% | 255 |
|
|
2021
Q3 | $1.67M | Buy |
8,362
+255
| +3% | +$55.4K | 0.01% | 456 |
|
|
2021
Q2 | $1.92M | Buy |
+8,107
| New | +$2.02M | 0.01% | 497 |
|
|
2020
Q3 | – | Sell |
-12,768
| Closed | -$2.4M | – | 445 |
|
|
2020
Q2 | $2.4M | Sell |
12,768
-7,373
| -37% | -$1.4M | 0.04% | 89 |
|
|
2020
Q1 | $3.57M | Buy |
+20,141
| New | +$3.91M | 0.07% | 84 |
|
|
2015
Q2 | – | Sell |
-20,345
| Closed | -$2.63M | – | 327 |
|
|
2015
Q1 | $2.63M | Sell |
20,345
-6,636
| -25% | -$771K | 0.02% | 174 |
|
|
2014
Q4 | $2.78M | Sell |
26,981
-4,800
| -15% | -$473K | 0.02% | 173 |
|
|
2014
Q3 | $2.88M | Buy |
31,781
+4,700
| +17% | +$439K | 0.02% | 148 |
|
|
2014
Q2 | $2.49M | Sell |
27,081
-35,900
| -57% | -$3.08M | 0.02% | 166 |
|
|
2014
Q1 | $5.27M | Buy |
+62,981
| New | +$5.19M | 0.04% | 94 |
|
|
2013
Q4 | – | Sell |
-55,781
| Closed | -$4.29M | – | 307 |
|
|
2013
Q3 | $4.29M | Buy |
55,781
+24,700
| +79% | +$1.93M | 0.04% | 105 |
|
|
2013
Q2 | $2.25M | Buy |
+31,081
| New | +$2.09M | 0.02% | 148 |
|
Other funds holding CI
VCM
VPM
Bridgewater Associates's CI Position: Q1 2026 in Review
Bridgewater Associates reduced its Cigna (CI) stake by 34% in Q1 2026, selling an estimated $32.1M and leaving 228,493 shares worth $61M. The position accounts for 0.27% of the portfolio, ranked #65.
Bridgewater Associates first reported a position in CI in Q2 2013 and has held it in 29 quarters since. The position peaked at $204M in Q2 2025. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.
- Bridgewater Associates held 228,493 shares of Cigna worth $61M as of Q1 2026.
- Bridgewater Associates sold 115,959 Cigna shares in Q1 2026, an estimated $32.1M.
- Cigna made up 0.27% of Bridgewater Associates's portfolio in Q1 2026, its #65 holding.
- Bridgewater Associates first reported a position in Cigna in Q2 2013 and has held it in 29 quarters since.
- Bridgewater Associates's Cigna position peaked at $204M in Q2 2025.
- 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.
Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.